ABC · updated 2026-10-16

New FDA-Cleared Al Tool Could Help Predict If Breast Cancer Will Return

See how ABC are framing this — we run every side, so you decide. News for humans, not bots: serious, civil discussion among real people, with the context and facts you need. Don't just watch: be on the air with your own video takes, polls and predictions.

EVERY NETWORK'S FRAMING

ABC

“NEW FDA-CLEARED AL TOOL COULD HELP PREDICT IF BREAST CANCER WILL RETURN ”

covered 2026-10-16 ▶ Be on the air with ABC

Watch the moment

KVUE

Dr. Heather Rogers MD, Dermatologist and Educator

Dr. Amy - Cancer Researcher & Cancer Survivor

Add your voice

Polls, predictions & fact-checks we ran live across networks — your take joins the running tally, compared across every network.

Topic poll · all networksWill insurers cover this new AI breast cancer tool within 2 years?

  • Yes — coverage fast-tracked 0%
  • Only for high-risk patients 0%
  • No — costs will block access 0%
  • It depends on the price tag 0%

Be the first to weigh in

Breast cancer costs the U.S. ~$28 billion in medical care yearly.

That figure, from the National Cancer Institute, covers direct treatment costs alone — not lost wages or caregiving. Tools that predict recurrence could reduce costly late-stage retreatment.

Topic poll · all networksWhen an FDA-cleared AI medical tool harms a patient, who bears primary liability?

  1. The treating physician
  2. The device manufacturer
  3. The hospital system
  4. The FDA itself
Guess, then reveal the answer

The device manufacturer

The conversation

No comments yet — be the first to add your voice when you're on the air. Civil, moderated, bot-free.

LIVE ROOMS Rooms open during live coverage 1 channel ▾
ABC ▶ Be on the air